Dissecting histone deacetylase 3 in multiple disease conditions: selective inhibition as a promising therapeutic strategy

N Adhikari, T Jha, B Ghosh - Journal of Medicinal Chemistry, 2021 - ACS Publications
The acetylation of histone and non-histone proteins has been implicated in several disease
states. Modulation of such epigenetic modifications has therefore made histone …

Epigenetic mechanisms of neurodegenerative diseases and acute brain injury

MJ Bertogliat, KC Morris-Blanco… - Neurochemistry …, 2020 - Elsevier
Epigenetic modifications are emerging as major players in the pathogenesis of
neurodegenerative disorders and susceptibility to acute brain injury. DNA and histone …

Fatty acid synthesis suppresses dietary polyunsaturated fatty acid use

A Worthmann, J Ridder, SYL Piel, I Evangelakos… - Nature …, 2024 - nature.com
Dietary polyunsaturated fatty acids (PUFA) are increasingly recognized for their health
benefits, whereas a high production of endogenous fatty acids–a process called de novo …

Histone deacetylase inhibitors: a therapeutic key in neurological disorders?

M Ziemka-Nalecz, J Jaworska… - … of Neuropathology & …, 2018 - academic.oup.com
Understanding the contribution of imbalance in protein acetylation levels and dysfunction of
transcription to neurodegenerative diseases provides the rationale for the use of epigenetic …

Histone deacetylase in neuropathology

R Gupta, RK Ambasta, P Kumar - Advances in Clinical Chemistry, 2021 - Elsevier
Neuroepigenetics, a new branch of epigenetics, plays an important role in the regulation of
gene expression. Neuroepigenetics is associated with holistic neuronal function and helps …

Mutant huntingtin protein interaction map implicates dysregulation of multiple cellular pathways in neurodegeneration of huntington's disease

S Podvin, SB Rosenthal, W Poon, E Wei… - Journal of …, 2022 - content.iospress.com
Background: Huntington's disease (HD) is a genetic neurodegenerative disease caused by
trinucleotide repeat (CAG) expansions in the human HTT gene encoding the huntingtin …

Transcriptional dysregulation in Huntington's disease: the role of histone deacetylases

S Sharma, R Taliyan - Pharmacological research, 2015 - Elsevier
Huntington's disease (HD) is a progressive neurological disorder for which there are no
disease-modifying treatments. Although, the exact underlying mechanism (s) leading to the …

Trehalose attenuates the gait ataxia and gliosis of spinocerebellar ataxia type 17 mice

ZZ Chen, CM Wang, GC Lee, HC Hsu, TL Wu… - Neurochemical …, 2015 - Springer
Abstract Spinocerebellar ataxia type 17 (SCA17) is caused by CAG/CAA repeat expansion
on the gene encoding a general transcription factor, TATA-box-binding protein (TBP). The …

Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation

KA Han, WH Shin, S Jung, W Seol, H Seo… - Human molecular …, 2017 - academic.oup.com
Parkinson's disease (PD) is characterized by slow, progressive degeneration of
dopaminergic neurons in the substantia nigra. The cause of neuronal death in PD is largely …

Histone deacetylase 3 indirectly modulates tubulin acetylation

T Bacon, C Seiler, M Wolny, R Hughes… - Biochemical …, 2015 - portlandpress.com
Histone deacetylase 3 (HDAC3), a member of the Class I subfamily of HDACs, is found in
both the nucleus and the cytoplasm. Its roles in the nucleus have been well characterized …